Monthly
US$200
Billed every month
Sign in to subscribeAs of 16 November 2026, for Atropine Sulfate Injection, 5 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 29 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 4 applicationsNo longer listed under review: 3 applicationsSupplement delivery: 2 applications
Current coverage may be incomplete
Free: up to 3 drugs, Monday digest. Sign in with Google or an email code. No card needed.
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Loaded records: 29 holders; 24 in the quality-and-efficacy consistency-evaluation category, and 5 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Yan Tai Wan Run Pharma Co., Ltd. romanized | Yan Tai Lu Yin Pharma Co., Ltd. romanized | 国药准字H20264941 | 2026/06/23 | 1ml:0.5mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Run Heng Pharmaceutical Co., Ltd. romanized | Jiangsu Run Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20264901 | 2026/06/23 | 1ml:0.5mg | Generic approved under the new chemical-drug registration classification | CDE |
| Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H41022686 | 2026/05/25 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Jiu Quan Da De Li Pharmaceutical Co., Ltd. romanized | Jiu Quan Da De Li Pharmaceutical Co., Ltd. romanized | 国药准字H62020772 | 2026/03/19 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xian Li Jun Pharmaceutical Co., Ltd. romanized | Xian Li Jun Pharmaceutical Co., Ltd. romanized | 国药准字H61021674 | 2025/12/31 | 1ml︰0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xian Li Jun Pharmaceutical Co., Ltd. romanized | Xian Li Jun Pharmaceutical Co., Ltd. romanized | 国药准字H61021675 | 2025/12/31 | 2ml︰1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H20258289 | 2025/12/16 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H41020226 | 2025/12/16 | 2ml:1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | 国药准字H41023675 | 2025/12/03 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | 国药准字H41023676 | 2025/12/03 | 2ml:1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Jiangsu Kai Yuan Pharma Co., Ltd. romanized | Kang Pu Pharma Co., Ltd. romanized | 国药准字H20255664 | 2025/10/14 | 1ml:0.5mg | Generic approved under the new chemical-drug registration classification | CDE |
| Dan Dong Yi Chuang Pharma Co., Ltd. romanized | Dan Dong Yi Chuang Pharma Co., Ltd. romanized | 国药准字H21022471 | 2025/08/22 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Henan Pu Rui Pharma Co., Ltd. romanized | Henan Pu Rui Pharma Co., Ltd. romanized | 国药准字H20255066 | 2025/07/30 | 1ml:0.5mg | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Dong Ting Pharma Co., Ltd. romanized | Hunan Dong Ting Pharma Co., Ltd. romanized | 国药准字H43020700 | 2025/07/28 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hunan Hai Shi Biopharmaceuticals Co., Ltd. romanized | Kang Pu Pharma Co., Ltd. romanized | 国药准字H20254725 | 2025/06/30 | 1ml:0.5mg | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34021900 | 2025/06/13 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34021899 | 2025/06/13 | 2ml:1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hubei Mei Lin Pharma Co., Ltd. romanized | Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H42020628 | 2025/01/14 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xi Nan Pharma Co., Ltd. romanized | Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020044 | 2024/11/20 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Fuzhou Hai Wang Fu Yao Pharmaceutical Co., Ltd. romanized | Fuzhou Hai Wang Fu Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20247198 | 2024/08/23 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shanghai He Feng Pharmaceutical Co., Ltd. romanized | Shanghai He Feng Pharmaceutical Co., Ltd. romanized | 国药准字H31021172 | 2024/08/20 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Sui Cheng Pharma Co., Ltd. romanized | Sui Cheng Pharma Co., Ltd. romanized | 国药准字H41021257 | 2024/04/01 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized | Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized | 国药准字H42021895 | 2023/12/14 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H34023679 | 2023/10/23 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hubei Xing Hua Pharmaceutical Co., Ltd. romanized | Hubei Xing Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20237122 | 2023/10/23 | 2ml:1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | Hunan Wu Zhou Tong Pharma Co., Ltd. romanized | 国药准字H43020903 | 2023/08/21 | 2ml:1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | Hunan Wu Zhou Tong Pharma Co., Ltd. romanized | 国药准字H20237099 | 2023/08/21 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Bai Zheng Pharma Co., Ltd. romanized | Bai Zheng Pharma Co., Ltd. romanized | 国药准字H41022450 | 2023/07/23 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H41020323 | 2023/06/12 | 2ml:1mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H41020324 | 2023/06/12 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H32021535 | 2023/03/28 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hangzhou Minsheng Pharmaceutical Co., Ltd | Hangzhou Minsheng Pharmaceutical Co., Ltd | 国药准字H20237033 | 2023/03/28 | 1ml: 0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021303 | 2023/03/28 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Topfond Pharmaceutical Co., Ltd. | Topfond Pharmaceutical Co., Ltd. | 国药准字H41020291 | 2022/08/01 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Tianjin Jin Yao Pharma Co., Ltd. romanized | Tianjin Jin Yao Pharma Co., Ltd. romanized | 国药准字H12020382 | 2022/03/25 | 1ml:0.5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
Loaded records: 130 distinct approval numbers and 65 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Jiangsu Run Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20264901 | 1ml:0.5mg | Category A | XA03BAA068B002010185560 | NHSA |
| Jiangsu Run Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20264901 | 1ml:0.5mg | Category A | XA03BAA068B002010285560 | NHSA |
| Jiangsu Kai Yuan Pharma Co., Ltd. romanized | 国药准字H20255664 | 1ml:0.5mg | Category A | XA03BAA068B002010183955 | NHSA |
| Henan Pu Rui Pharma Co., Ltd. romanized | 国药准字H20255066 | 1ml:0.5mg | Category A | XA03BAA068B002010184683 | NHSA |
| Hunan Hai Shi Biopharmaceuticals Co., Ltd. romanized | 国药准字H20254725 | 1ml:0.5mg | Category A | XA03BAA068B002010185042 | NHSA |
| Henan Pu Rui Pharma Co., Ltd. romanized | 国药准字H20255066 | 1ml:0.5mg | Category A | XA03BAA068B002010284683 | NHSA |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H20258289 | 1ml:0.5mg | Category A | XA03BAA068B002020103216 | NHSA |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | 国药准字H44022488 | 1ml:0.5mg | Category A | XA03BAA068B002010100315 | NHSA |
| Guangdong Lei Yun Shang Pharma Co., Ltd. romanized | 国药准字H44023850 | 1ml:0.5mg | Category A | XA03BAA068B002010100365 | NHSA |
| Shanghai He Feng Pharmaceutical Co., Ltd. romanized | 国药准字H31021172 | 1ml:0.5mg | Category A | XA03BAA068B002010100673 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H12020382 | 1ml:0.5mg | Category A | XA03BAA068B002010100874 | NHSA |
| Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020044 | 1ml:0.5mg | Category A | XA03BAA068B002010100978 | NHSA |
| Dan Dong Yi Chuang Pharma Co., Ltd. romanized | 国药准字H21022471 | 1ml:0.5mg | Category A | XA03BAA068B002010101157 | NHSA |
| Liaoning Tian Long Pharma Co., Ltd. romanized | 国药准字H21020104 | 2ml:1mg | Category A | XA03BAA068B002010101258 | NHSA |
| Jiangsu Lian Shui Pharmaceutical Co., Ltd. romanized | 国药准字H32020166 | 1ml∶0.5mg | Category A | XA03BAA068B002010101466 | NHSA |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | 国药准字H32020045 | 1ml:0.5mg | Category A | XA03BAA068B002010101518 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H32022715 | 1ml:10mg | Category A | XA03BAA068B002010101559 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H32022467 | 1ml:0.5mg | Category A | XA03BAA068B002010101631 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H32021535 | 1ml:0.5mg | Category A | XA03BAA068B002010101708 | NHSA |
| Hubei Xing Hua Pharmaceutical Co., Ltd. romanized | 国药准字H42020590 | 1ml∶0.5mg | Category A | XA03BAA068B002010101788 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021158 | 1ml:5mg | Category A | XA03BAA068B002010101871 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021500 | 1ml:0.5mg | Category A | XA03BAA068B002010101884 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020629 | 1ml:2mg | Category A | XA03BAA068B002010101885 | NHSA |
| Wuhan Fu Xing Bio Pharma Co., Ltd. romanized | 国药准字H42023000 | 1ml:0.5mg | Category A | XA03BAA068B002010101962 | NHSA |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42021993 | 1ml:0.5mg | Category A | XA03BAA068B002010102000 | NHSA |
| Chengdu Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H51022767 | 1ml:0.5mg | Category A | XA03BAA068B002010102065 | NHSA |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021303 | 1ml:0.5mg | Category A | XA03BAA068B002010102068 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H51021427 | 1ml:0.5mg | Category A | XA03BAA068B002010102087 | NHSA |
| Xian Li Jun Pharmaceutical Co., Ltd. romanized | 国药准字H61021674 | 1ml:0.5mg | Category A | XA03BAA068B002010102503 | NHSA |
| Hebei Wu Luo Pharma Co., Ltd. romanized | 国药准字H20057907 | 2ml:1mg | Category A | XA03BAA068B002010102601 | NHSA |
| Shen Wei Pharma Group Co., Ltd. romanized | 国药准字H13021500 | 1ml:0.5mg | Category A | XA03BAA068B002010102729 | NHSA |
| Wan Bang De Pharmaceutical Group Co., Ltd. romanized | 国药准字H13022141 | 2ml:1mg | Category A | XA03BAA068B002010102779 | NHSA |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H13022339 | 1ml:0.5mg | Category A | XA03BAA068B002010102829 | NHSA |
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | 国药准字H41023675 | 1ml:0.5mg | Category A | XA03BAA068B002010102994 | NHSA |
| Henan Tong Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H41021848 | 1ml:5mg | Category A | XA03BAA068B002010103008 | NHSA |
| Xu Chang Wei Lai Pharmaceutical Co., Ltd. romanized | 国药准字H41022450 | 1ml:0.5mg | Category A | XA03BAA068B002010103087 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H41020291 | 1ml:0.5mg | Category A | XA03BAA068B002010103098 | NHSA |
| Jiao Zuo Fu Rui Tang Pharmaceutical Co., Ltd. romanized | 国药准字H41021272 | 1ml:0.5mg | Category A | XA03BAA068B002010103130 | NHSA |
| Kai Feng Pharmaceutical (Group) Co., Ltd. romanized | 国药准字H41021817 | 1ml:0.5mg | Category A | XA03BAA068B002010103139 | NHSA |
| Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H41022686 | 1ml:0.5mg | Category A | XA03BAA068B002010103140 | NHSA |
| Shanghai Pu Jin Lin Zhou Pharmaceutical Co., Ltd. romanized | 国药准字H41022645 | 1ml:0.5mg | Category A | XA03BAA068B002010103143 | NHSA |
| Henan Li Xin Pharmaceutical Co., Ltd. romanized | 国药准字H41024295 | 1ml:0.5mg | Category A | XA03BAA068B002010103168 | NHSA |
| Nan Yang Pu Kang Heng Wang Pharma Co., Ltd. romanized | 国药准字H41022517 | 1ml:0.5mg | Category A | XA03BAA068B002010103170 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H41021257 | 1ml:0.5mg | Category A | XA03BAA068B002010103204 | NHSA |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H41020226 | 2ml:1mg | Category A | XA03BAA068B002010103216 | NHSA |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H41020324 | 1ml:0.5mg | Category A | XA03BAA068B002010103257 | NHSA |
| Zhong Jia Bio Technology (Hubei Sheng) Co., Ltd. romanized | 国药准字H20053921 | 1ml:0.5mg | Category A | XA03BAA068B002010103377 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H37022051 | 1ml:0.5mg | Category A | XA03BAA068B002010104152 | NHSA |
| Zhong Fu Pharma Co., Ltd. romanized | 国药准字H37021060 | 1ml:0.5mg | Category A | XA03BAA068B002010104180 | NHSA |
| Ma An Shan Feng Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H34023616 | 1ml:0.5mg | Category A | XA03BAA068B002010104288 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H34023679 | 1ml:0.5mg | Category A | XA03BAA068B002010104383 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34021900 | 1ml:0.5mg | Category A | XA03BAA068B002010104451 | NHSA |
| Hangzhou Minsheng Pharmaceutical Co., Ltd | 国药准字H33020089 | 1ml:5mg | Category A | XA03BAA068B002010104494 | NHSA |
| Zhejiang Xian Ju Pharmaceutical Co., Ltd. romanized | 国药准字H20053311 | 1ml:0.5mg | Category A | XA03BAA068B002010104735 | NHSA |
| Fujian Hui Tian Bio Pharma Co., Ltd. romanized | 国药准字H35020369 | 1ml:0.5mg | Category A | XA03BAA068B002010104774 | NHSA |
| Fuzhou Hai Wang Fu Yao Pharmaceutical Co., Ltd. romanized | 国药准字H35020999 | 1ml:5mg | Category A | XA03BAA068B002010104827 | NHSA |
| Hunan Wu Zhou Tong Pharma Co., Ltd. romanized | 国药准字H43020904 | 1ml:5mg | Category A | XA03BAA068B002010104998 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H45020850 | 1ml:0.5mg | Category A | XA03BAA068B002010105206 | NHSA |
| Hainan Pharmaceutical Factory Co., Ltd. romanized | 国药准字H46020463 | 1ml:0.5mg | Category A | XA03BAA068B002010105840 | NHSA |
| Gansu Lan Yao Pharma Co., Ltd. romanized | 国药准字H62020561 | 1ml:0.5mg | Category A | XA03BAA068B002010105863 | NHSA |
| Jiu Quan Da De Li Pharmaceutical Co., Ltd. romanized | 国药准字H62020772 | 1ml:0.5mg | Category A | XA03BAA068B002010105868 | NHSA |
| Guo Yao Group Xinjiang Pharmaceutical Co., Ltd. romanized | 国药准字H65020081 | 1ml:0.5mg | Category A | XA03BAA068B002010106014 | NHSA |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20237099 | 1ml:0.5mg | Category A | XA03BAA068B002010183048 | NHSA |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | 国药准字H44022488 | 1ml:0.5mg | Category A | XA03BAA068B002010200315 | NHSA |
| Shanghai He Feng Pharmaceutical Co., Ltd. romanized | 国药准字H31021172 | 1ml:0.5mg | Category A | XA03BAA068B002010200673 | NHSA |
| Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020044 | 1ml:0.5mg | Category A | XA03BAA068B002010200978 | NHSA |
| Dan Dong Yi Chuang Pharma Co., Ltd. romanized | 国药准字H21022471 | 1ml:0.5mg | Category A | XA03BAA068B002010201157 | NHSA |
| Jiangsu Lian Shui Pharmaceutical Co., Ltd. romanized | 国药准字H32020166 | 1ml∶0.5mg | Category A | XA03BAA068B002010201466 | NHSA |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | 国药准字H32022526 | 1ml:5mg | Category A | XA03BAA068B002010201518 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H32022466 | 1ml:5mg | Category A | XA03BAA068B002010201631 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H32021535 | 1ml:0.5mg | Category A | XA03BAA068B002010201708 | NHSA |
| Jiangsu Lang Ou Pharma Co., Ltd. romanized | 国药准字H32021060 | 1ml:0.5mg | Category A | XA03BAA068B002010201723 | NHSA |
| Hubei Xing Hua Pharmaceutical Co., Ltd. romanized | 国药准字H42020590 | 1ml∶0.5mg | Category A | XA03BAA068B002010201788 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021158 | 1ml:5mg | Category A | XA03BAA068B002010201871 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021498 | 1ml:1mg | Category A | XA03BAA068B002010201884 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020629 | 1ml:2mg | Category A | XA03BAA068B002010201885 | NHSA |
| Wuhan Fu Xing Bio Pharma Co., Ltd. romanized | 国药准字H42023000 | 1ml:0.5mg | Category A | XA03BAA068B002010201962 | NHSA |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022057 | 1ml:1mg | Category A | XA03BAA068B002010202000 | NHSA |
| Chengdu Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H51023079 | 1ml:5mg | Category A | XA03BAA068B002010202065 | NHSA |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021303 | 1ml:0.5mg | Category A | XA03BAA068B002010202068 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H51021428 | 1ml:5mg | Category A | XA03BAA068B002010202087 | NHSA |
| Xian Li Jun Pharmaceutical Co., Ltd. romanized | 国药准字H61021674 | 1ml:0.5mg | Category A | XA03BAA068B002010202503 | NHSA |
| Hebei Wu Luo Pharma Co., Ltd. romanized | 国药准字H20057907 | 2ml:1mg | Category A | XA03BAA068B002010202601 | NHSA |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H13022339 | 1ml:0.5mg | Category A | XA03BAA068B002010202829 | NHSA |
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | 国药准字H41023675 | 1ml:0.5mg | Category A | XA03BAA068B002010202994 | NHSA |
| Xu Chang Wei Lai Pharmaceutical Co., Ltd. romanized | 国药准字H41022450 | 1ml:0.5mg | Category A | XA03BAA068B002010203087 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H41020291 | 1ml:0.5mg | Category A | XA03BAA068B002010203098 | NHSA |
| Jiao Zuo Fu Rui Tang Pharmaceutical Co., Ltd. romanized | 国药准字H41021273 | 1ml:5mg | Category A | XA03BAA068B002010203130 | NHSA |
| Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H41022686 | 1ml:0.5mg | Category A | XA03BAA068B002010203140 | NHSA |
| Nan Yang Pu Kang Heng Wang Pharma Co., Ltd. romanized | 国药准字H41022517 | 1ml:0.5mg | Category A | XA03BAA068B002010203170 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H41021257 | 1ml:0.5mg | Category A | XA03BAA068B002010203204 | NHSA |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H41020226 | 2ml:1mg | Category A | XA03BAA068B002010203216 | NHSA |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H41020324 | 1ml:0.5mg | Category A | XA03BAA068B002010203257 | NHSA |
| Zhong Jia Bio Technology (Hubei Sheng) Co., Ltd. romanized | 国药准字H20053923 | 1ml:5mg | Category A | XA03BAA068B002010203377 | NHSA |
| Zhong Fu Pharma Co., Ltd. romanized | 国药准字H37021059 | 1ml:5mg | Category A | XA03BAA068B002010204180 | NHSA |
| Ma An Shan Feng Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H34023617 | 1ml:5mg | Category A | XA03BAA068B002010204288 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H34023677 | 1ml:5mg | Category A | XA03BAA068B002010204383 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H45020850 | 1ml:0.5mg | Category A | XA03BAA068B002010205206 | NHSA |
| Gansu Lan Yao Pharma Co., Ltd. romanized | 国药准字H62020796 | 1ml:1mg | Category A | XA03BAA068B002010205863 | NHSA |
| Jiu Quan Da De Li Pharmaceutical Co., Ltd. romanized | 国药准字H62020772 | 1ml:0.5mg | Category A | XA03BAA068B002010205868 | NHSA |
| Guo Yao Group Xinjiang Pharmaceutical Co., Ltd. romanized | 国药准字H65020079 | 1ml:5mg | Category A | XA03BAA068B002010206014 | NHSA |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20237099 | 1ml:0.5mg | Category A | XA03BAA068B002010283048 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021501 | 1ml:2mg | Category A | XA03BAA068B002010301884 | NHSA |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42021994 | 1ml:5mg | Category A | XA03BAA068B002010302000 | NHSA |
| Jiao Zuo Fu Rui Tang Pharmaceutical Co., Ltd. romanized | 国药准字H41021272 | 1ml:0.5mg | Category A | XA03BAA068B002010303130 | NHSA |
| Hainan Pharmaceutical Factory Co., Ltd. Pharmaceutical Er Factory romanized | 国药准字H41025476 | 1ml:0.5mg | Category A | XA03BAA068B002010303141 | NHSA |
| Zhong Fu Pharma Co., Ltd. romanized | 国药准字H37021060 | 1ml:0.5mg | Category A | XA03BAA068B002010304180 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H34023679 | 1ml:0.5mg | Category A | XA03BAA068B002010304383 | NHSA |
| Gansu Lan Yao Pharma Co., Ltd. romanized | 国药准字H62020559 | 1ml:5mg | Category A | XA03BAA068B002010305863 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021499 | 1ml:5mg | Category A | XA03BAA068B002010401884 | NHSA |
| Jiao Zuo Fu Rui Tang Pharmaceutical Co., Ltd. romanized | 国药准字H41021273 | 1ml:5mg | Category A | XA03BAA068B002010403130 | NHSA |
| Zhong Fu Pharma Co., Ltd. romanized | 国药准字H37021059 | 1ml:5mg | Category A | XA03BAA068B002010404180 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H34023679 | 1ml:0.5mg | Category A | XA03BAA068B002010404383 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021499 | 1ml:5mg | Category A | XA03BAA068B002010501884 | NHSA |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | 国药准字H44022487 | 2ml:1mg | Category A | XA03BAA068B002020100315 | NHSA |
| Shanghai He Feng Pharmaceutical Co., Ltd. romanized | 国药准字H31021057 | 2ml:10mg | Category A | XA03BAA068B002020100673 | NHSA |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H12020383 | 1ml:1mg | Category A | XA03BAA068B002020100874 | NHSA |
| Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020046 | 1ml:1mg | Category A | XA03BAA068B002020100978 | NHSA |
| Jiangsu Lian Shui Pharmaceutical Co., Ltd. romanized | 国药准字H32020167 | 2ml∶1mg | Category A | XA03BAA068B002020101466 | NHSA |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | 国药准字H32022527 | 2ml:1mg | Category A | XA03BAA068B002020101518 | NHSA |
| Jin Ling Pharma Co., Ltd. Nanjing Jin Ling Pharmaceutical Factory romanized | 国药准字H32021849 | 1ml:5mg | Category A | XA03BAA068B002020101559 | NHSA |
| Hubei Xing Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20237122 | 2ml:1mg | Category A | XA03BAA068B002020101788 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021159 | 2ml:1mg | Category A | XA03BAA068B002020101871 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021501 | 1ml:2mg | Category A | XA03BAA068B002020101884 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020630 | 1ml:5mg | Category A | XA03BAA068B002020101885 | NHSA |
| Chengdu Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H51023078 | 2ml:1mg | Category A | XA03BAA068B002020102065 | NHSA |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021304 | 1ml:5mg | Category A | XA03BAA068B002020102068 | NHSA |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H51021426 | 2ml:1mg | Category A | XA03BAA068B002020102087 | NHSA |
| Xian Li Jun Pharmaceutical Co., Ltd. romanized | 国药准字H61021675 | 2ml:1mg | Category A | XA03BAA068B002020102503 | NHSA |
| Hebei Wu Luo Pharma Co., Ltd. romanized | 国药准字H20057891 | 1ml:5mg | Category A | XA03BAA068B002020102601 | NHSA |
| Shen Wei Pharma Group Co., Ltd. romanized | 国药准字H13021450 | 2ml:1mg | Category A | XA03BAA068B002020102729 | NHSA |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H13022532 | 2ml:1mg | Category A | XA03BAA068B002020102829 | NHSA |
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | 国药准字H41023676 | 2ml:1mg | Category A | XA03BAA068B002020102994 | NHSA |
| Xu Chang Wei Lai Pharmaceutical Co., Ltd. romanized | 国药准字H41022449 | 2ml:1mg | Category A | XA03BAA068B002020103087 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H41020120 | 2ml:1mg | Category A | XA03BAA068B002020103098 | NHSA |
| Kai Feng Pharmaceutical (Group) Co., Ltd. romanized | 国药准字H41021818 | 2ml:1mg | Category A | XA03BAA068B002020103139 | NHSA |
| Shanghai Pu Jin Lin Zhou Pharmaceutical Co., Ltd. romanized | 国药准字H41022645 | 1ml:0.5mg | Category A | XA03BAA068B002020103143 | NHSA |
| Jiangxi Ren Ke Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H41024263 | 1ml:1mg | Category A | XA03BAA068B002020103162 | NHSA |
| Henan Li Xin Pharmaceutical Co., Ltd. romanized | 国药准字H41024294 | 2ml:1mg | Category A | XA03BAA068B002020103168 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H41021256 | 2ml:1mg | Category A | XA03BAA068B002020103204 | NHSA |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H41020323 | 2ml:1mg | Category A | XA03BAA068B002020103257 | NHSA |
| Zhong Jia Bio Technology (Hubei Sheng) Co., Ltd. romanized | 国药准字H20053922 | 2ml:1mg | Category A | XA03BAA068B002020103377 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H37022050 | 1ml:5mg | Category A | XA03BAA068B002020104152 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H34023678 | 2ml:1mg | Category A | XA03BAA068B002020104383 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34023134 | 1ml:1mg | Category A | XA03BAA068B002020104451 | NHSA |
| Hangzhou Minsheng Pharmaceutical Co., Ltd | 国药准字H20237033 | 1ml: 0.5mg | Category A | XA03BAA068B002020104494 | NHSA |
| Fujian Hui Tian Bio Pharma Co., Ltd. romanized | 国药准字H35020368 | 2ml:1mg | Category A | XA03BAA068B002020104774 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H45020844 | 2ml:1mg | Category A | XA03BAA068B002020105206 | NHSA |
| Gansu Lan Yao Pharma Co., Ltd. romanized | 国药准字H62020560 | 2ml:1mg | Category A | XA03BAA068B002020105863 | NHSA |
| Guo Yao Group Xinjiang Pharmaceutical Co., Ltd. romanized | 国药准字H65020080 | 2ml:1mg | Category A | XA03BAA068B002020106014 | NHSA |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | 国药准字H44022487 | 2ml:1mg | Category A | XA03BAA068B002020200315 | NHSA |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H12020383 | 1ml:1mg | Category A | XA03BAA068B002020200874 | NHSA |
| Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020045 | 1ml:5mg | Category A | XA03BAA068B002020200978 | NHSA |
| Jiangsu Lian Shui Pharmaceutical Co., Ltd. romanized | 国药准字H32020167 | 2ml∶1mg | Category A | XA03BAA068B002020201466 | NHSA |
| Hubei Xing Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20237122 | 2ml:1mg | Category A | XA03BAA068B002020201788 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021159 | 2ml:1mg | Category A | XA03BAA068B002020201871 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021500 | 1ml:0.5mg | Category A | XA03BAA068B002020201884 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020630 | 1ml:5mg | Category A | XA03BAA068B002020201885 | NHSA |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021304 | 1ml:5mg | Category A | XA03BAA068B002020202068 | NHSA |
| Xian Li Jun Pharmaceutical Co., Ltd. romanized | 国药准字H61021675 | 2ml:1mg | Category A | XA03BAA068B002020202503 | NHSA |
| Hebei Wu Luo Pharma Co., Ltd. romanized | 国药准字H20057891 | 1ml:5mg | Category A | XA03BAA068B002020202601 | NHSA |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H13022532 | 2ml:1mg | Category A | XA03BAA068B002020202829 | NHSA |
| Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | 国药准字H41023676 | 2ml:1mg | Category A | XA03BAA068B002020202994 | NHSA |
| Xu Chang Wei Lai Pharmaceutical Co., Ltd. romanized | 国药准字H41022449 | 2ml:1mg | Category A | XA03BAA068B002020203087 | NHSA |
| Kai Feng Pharmaceutical (Group) Co., Ltd. romanized | 国药准字H41021818 | 2ml:1mg | Category A | XA03BAA068B002020203139 | NHSA |
| Henan Li Xin Pharmaceutical Co., Ltd. romanized | 国药准字H41024294 | 2ml:1mg | Category A | XA03BAA068B002020203168 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H41021256 | 2ml:1mg | Category A | XA03BAA068B002020203204 | NHSA |
| Henan Run Hong Pharmaceutical Co., Ltd. romanized | 国药准字H41020323 | 2ml:1mg | Category A | XA03BAA068B002020203257 | NHSA |
| Hangzhou Minsheng Pharmaceutical Co., Ltd | 国药准字H20237033 | 1ml: 0.5mg | Category A | XA03BAA068B002020204494 | NHSA |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H43020903 | 2ml:1mg | Category A | XA03BAA068B002020204998 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H45020844 | 2ml:1mg | Category A | XA03BAA068B002020205206 | NHSA |
| Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020046 | 1ml:1mg | Category A | XA03BAA068B002020300978 | NHSA |
| Hua Zhong Pharma Co., Ltd. romanized | 国药准字H42021498 | 1ml:1mg | Category A | XA03BAA068B002020301884 | NHSA |
| Jia Shi (Hunan) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H43020903 | 2ml:1mg | Category A | XA03BAA068B002020304998 | NHSA |
| Xi Nan Pharma Co., Ltd. romanized | 国药准字H50020045 | 1ml:5mg | Category A | XA03BAA068B002020400978 | NHSA |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | 国药准字H44024022 | 1ml:5mg | Category A | XA03BAA068B002030100315 | NHSA |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H12020384 | 1ml:5mg | Category A | XA03BAA068B002030100874 | NHSA |
| Jiangsu Lang Ou Pharma Co., Ltd. romanized | 国药准字H32021058 | 1ml:5mg | Category A | XA03BAA068B002030101723 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021160 | 1ml:0.5mg | Category A | XA03BAA068B002030101871 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020628 | 1ml:0.5mg | Category A | XA03BAA068B002030101885 | NHSA |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021302 | 2ml:1mg | Category A | XA03BAA068B002030102068 | NHSA |
| Hebei Wu Luo Pharma Co., Ltd. romanized | 国药准字H20057912 | 1ml:0.5mg | Category A | XA03BAA068B002030102601 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H41020290 | 1ml:5mg | Category A | XA03BAA068B002030103098 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H37022052 | 2ml:1mg | Category A | XA03BAA068B002030104152 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34021899 | 2ml:1mg | Category A | XA03BAA068B002030104451 | NHSA |
| Guangdong Nan Guo Pharma Co., Ltd. romanized | 国药准字H44024022 | 1ml:5mg | Category A | XA03BAA068B002030200315 | NHSA |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H12020384 | 1ml:5mg | Category A | XA03BAA068B002030200874 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021160 | 1ml:0.5mg | Category A | XA03BAA068B002030201871 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020628 | 1ml:0.5mg | Category A | XA03BAA068B002030201885 | NHSA |
| Chengdu Shi Hai Tong Pharma Co., Ltd. romanized | 国药准字H51021302 | 2ml:1mg | Category A | XA03BAA068B002030202068 | NHSA |
| Hebei Wu Luo Pharma Co., Ltd. romanized | 国药准字H20057912 | 1ml:0.5mg | Category A | XA03BAA068B002030202601 | NHSA |
| Kai Feng Pharmaceutical (Group) Co., Ltd. romanized | 国药准字H41021817 | 1ml:0.5mg | Category A | XA03BAA068B002030203139 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34021899 | 2ml:1mg | Category A | XA03BAA068B002030204451 | NHSA |
| Tianjin Jin Yao Pharma Co., Ltd. romanized | 国药准字H12020385 | 5ml:25mg | Category A | XA03BAA068B002040100874 | NHSA |
| Jiangsu Lang Ou Pharma Co., Ltd. romanized | 国药准字H32021059 | 2ml:1mg | Category A | XA03BAA068B002040101723 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021161 | 2ml:10mg | Category A | XA03BAA068B002040101871 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020627 | 1ml:10mg | Category A | XA03BAA068B002040101885 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34023134 | 1ml:1mg | Category A | XA03BAA068B002040104451 | NHSA |
| Jiangsu Lang Ou Pharma Co., Ltd. romanized | 国药准字H32021059 | 2ml:1mg | Category A | XA03BAA068B002040201723 | NHSA |
| Hubei Ke Lun Pharma Co., Ltd. romanized | 国药准字H42021161 | 2ml:10mg | Category A | XA03BAA068B002040201871 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H42020627 | 1ml:10mg | Category A | XA03BAA068B002040201885 | NHSA |
| Anhui Chang Jiang Pharma Co., Ltd. romanized | 国药准字H34021900 | 1ml:0.5mg | Category A | XA03BAA068B002040204451 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H12020382 | 1ml:0.5mg | Category A | XA03BAA068B002050100874 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Loaded records: 5 filings and 3 distinct first applicants.
Generic 5
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hubei Jin Yao Pharma Co., Ltd. romanized | CYHS2502347 | Generic | 2025/07/03 | Not stated by source | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2602756 | Generic | 2026/11/09 | Not stated by source | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2602755 | Generic | 2026/11/09 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2602807 | Generic | 2026/11/13 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2602806 | Generic | 2026/11/13 | Not stated by source | CDE |
Loaded records: 4 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2602756 | Generic | 2026/11/09 | Not stated by source | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2602755 | Generic | 2026/11/09 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2602807 | Generic | 2026/11/13 | Not stated by source | CDE |
| Jiangsu Fu Bang Pharma Co., Ltd. romanized | CYHS2602806 | Generic | 2026/11/13 | Not stated by source | CDE |
Non-component matches: 14 companies with A status and 6 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 硫酸阿托品 · No verified English name | C-SQUARED PHARMA LIMITED | Y20250000139 | I | Exact ingredient | 2025/05/28 | CDE |
| 硫酸阿托品 · No verified English name | Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | Y20240001172 | A | Exact ingredient | 2026/03/30 | CDE |
| 硫酸阿托品 · No verified English name | Dan Dong Yi Chuang Pharma Co., Ltd. romanized | Y20240000600 | A | Exact ingredient | 2025/12/20 | CDE |
| 硫酸阿托品 · No verified English name | Yan Tai Wan Run Pharma Co., Ltd. romanized | Y20230000799 | A | Exact ingredient | 2026/03/17 | CDE |
| 硫酸阿托品 · No verified English name | Katsura Chemical Co., Ltd. | Y20230000668 | I | Exact ingredient | 2025/02/21 | CDE |
| 硫酸阿托品 · No verified English name | Resonance Laboratories Pvt. Ltd | Y20230000047 | A | Exact ingredient | 2026/09/22 | CDE |
| 硫酸阿托品 · No verified English name | ROLABO OUTSOURCING, S.L. | Y20230000080 | A | Exact ingredient | 2026/04/15 | CDE |
| 硫酸阿托品 · No verified English name | Alchem International Private Limited | Y20210000537 | I | Exact ingredient | 2024/07/23 | CDE |
| 硫酸阿托品 · No verified English name | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | Y20210001099 | A | Exact ingredient | 2024/01/23 | CDE |
| 硫酸阿托品 · No verified English name | Sichuan Ren An Pharma Co., Ltd. romanized | Y20210000910 | A | Exact ingredient | 2024/07/12 | CDE |
| 硫酸阿托品 · No verified English name | Hubei Heng Di Pharma Co., Ltd. romanized | Y20210000435 | A | Exact ingredient | 2025/06/13 | CDE |
| 硫酸阿托品 · No verified English name | Nuray Chemicals Pvt. Ltd. | Y20200001274 | I | Exact ingredient | 2023/08/01 | CDE |
| 硫酸阿托品 · No verified English name | C-SQUARED PHARMA S.A.R.L. | Y20200001436 | I | Exact ingredient | 2024/01/29 | CDE |
| 硫酸阿托品 · No verified English name | Katsura Chemical Co., Ltd. | Y20200000725 | I | Exact ingredient | 2020/09/17 | CDE |
| 硫酸阿托品 · No verified English name | Shao Xing Min Sheng Pharmaceuticals Co., Ltd. romanized | Y20190021160 | A | Exact ingredient | 2025/01/09 | CDE |
| 硫酸阿托品 · No verified English name | Shao Xing Min Sheng Pharmaceuticals Co., Ltd. romanized | Y20190008455 | A | Exact ingredient | — | CDE |
| 硫酸阿托品 · No verified English name | Henan Pu Rui Pharmaceutical Co., Ltd. romanized | Y20190006745 | A | Exact ingredient | 2026/07/17 | CDE |
| 硫酸阿托品 · No verified English name | Guangzhou Bai Yun Shan Han Fang Xian Dai Pharma Co., Ltd. romanized | Y20190005707 | A | Exact ingredient | 2026/08/05 | CDE |
| 硫酸阿托品 · No verified English name | Hua Run Shuang He Pharma Co., Ltd. romanized | Y20190004132 | A | Exact ingredient | 2025/01/04 | CDE |
| 硫酸阿托品 · No verified English name | SCL Lifesciences Limited | Y20190000383 | A | Exact ingredient | 2026/10/10 | CDE |
| 硫酸阿托品 · No verified English name | Changzhou Kang Pu Pharma Co., Ltd. romanized | Y20170001036 | A | Exact ingredient | 2024/06/06 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/16 06:35. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
CYHS2602807
Fact date: 2026/11/13 · Site observation date: 2026/11/14
View source ↗CYHS2602806
Fact date: 2026/11/13 · Site observation date: 2026/11/14
View source ↗CYHS2501817
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/05/20
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗CYHS2602756
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗CYHS2602755
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗CYHB2550407
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2025/12/19
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/03); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 13
NMPA · Table row 13 ↗ View source ↗CYHB2550406
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2025/12/19
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/03); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 12
NMPA · Table row 12 ↗ View source ↗CYHB2550407
Fact date: 2026/11/03 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 13 ↗CYHB2550406
Fact date: 2026/11/03 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 12 ↗Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
First index-page publication dates: 2026-10-29 to 2026-11-13; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 11/30; discovered pending details: 9. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy
No account needed.
Covers all drugs in the loaded CDE records, not only this one: weekly acceptance counts, top-10 lists and definitions. View the latest report